Trials / Completed
CompletedNCT04795804
Human Milk Oligossaccharide and Acetate Production in Vivo
The Effects of Human-like Milk Oligosaccharide and Resistant Starch on Acetate Production and Human Substrate Metabolism
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- Male
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The study investigators hypothesize (1) that the SCFA/acetate metabolism differs between metabolic phenotypes and (2) that using a mixture of fibres that differ in degree of polymerization and branching namely a resistant starch and a human-like milk oligosaccharide enhance the acetate availability in the distal colon and systemic circulation, consequently leading to its metabolic effects. To study this, the investigators will supplement lean, normoglycaemic vs. overweight/obese, prediabetic men with the fibre mixture the day before the clinical investigation day (CID) and study during the CID its effects on fasting and postprandial substrate and energy metabolism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Human Milk Oligossaccharide | The day before the CIDs, the participants receive the supplements 3x a day in randomized order |
| DIETARY_SUPPLEMENT | Maltodextrin | The day before the CIDs, the participants receive the supplements 3x a day in randomized order |
| DIETARY_SUPPLEMENT | Human Milk Oligossaccharide and resistant starch | The day before the CIDs, the participants receive the supplements 3x a day in randomized order |
Timeline
- Start date
- 2020-02-04
- Primary completion
- 2021-10-15
- Completion
- 2021-10-15
- First posted
- 2021-03-12
- Last updated
- 2021-11-03
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04795804. Inclusion in this directory is not an endorsement.